Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer.
Cartwright TH, Cohn A, Varkey JA, Chen YM, Szatrowski TP, Cox JV, Schulz JJ. Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. J Clin Oncol. 2002 Jan 01; 20(1):160-4.